Bioaffinity Technologies, Inc. (BIAF) - Form 8-K Summary
Business Context and Reporting Period
Bioaffinity Technologies, Inc., a Delaware corporation, filed this Current Report on Form 8-K on May 8, 2026. The filing serves to announce the issuance of a press release containing financial information for the first quarter ended March 31, 2026. The company is designated as an emerging growth company and trades on The Nasdaq Stock Market LLC under the symbols BIAF (Common Stock) and BIAFW (Warrants).
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document explicitly states that the financial information for the quarter ended March 31, 2026, is included in the attached press release (Exhibit 99.1) rather than within the body of this Form 8-K.
Material Changes
No material changes versus the prior comparable period are detailed in this filing text. The document functions solely as a notification of the press release's existence and does not summarize the comparative financial performance.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and the attached press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, nor will it be incorporated by reference into any other SEC filings. No specific guidance, outlook, or risk factors are enumerated in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 8, 2026) for actual Q1 2026 financial figures.
- Verify the company's status as an emerging growth company and its implications for financial reporting.
- Confirm the trading status of Common Stock (BIAF) and Warrants (BIAFW) on The Nasdaq Stock Market LLC.
- Note that the financial data in the press release is not incorporated by reference into this filing.